This article is part of Bain’s 2024 Global Private Equity Report
It’s safe to say the private equity industry has never seen anything quite like what’s happened over
Venture investment in biopharma and medtech companies ended 2024 with strong performance, as total investment amounts in both sectors outpaced 2023 despite fewer rounds. Biopharma saw $26 billion invested across 416 rounds,
In its recent strategic operating plan update, the Internal Revenue Service (“IRS”) delineated its future priorities, notably an enhanced audit focus targeting high-net-worth individuals, multinational corporations, and partnerships. The alternative investment industry
Access Denied You don’t have permission to access “http://www.spglobal.com/market-intelligence/en/news-insights/articles/2024/4/global-venture-capital-investment-value-volume-down-in-q1-2024-81180407” on this server. Reference #18.ead3c17.1741508651.36202489 https://errors.edgesuite.net/18.ead3c17.1741508651.36202489 Source link
Overall outlook Heading into 2024, the conditions for raising venture capital will continue to be challenging. We expect we will see many companies compete to fundraise in 2024. There are a large
Sectors Information technology, healthcare and business and financial services ranked as the top three sectors for the quarter. Investment into healthcare increased by 10%, while both information technology and business and financial
Access Denied You don’t have permission to access “http://www.spglobal.com/market-intelligence/en/news-insights/articles/2024/4/private-equity-venture-capital-entries-up-in-value-in-q1-2024-81225611” on this server. Reference #18.8ce5c417.1741497060.7a9e5d8 https://errors.edgesuite.net/18.8ce5c417.1741497060.7a9e5d8 Source link
We will continue to see liquidity issues. This is hardly surprising given that some $4.1 trillion² is still tied up in 55,000 companies in the US startup ecosystem. The new administration could
Free Newsletter Get the hottest Fintech Switzerland News once a month in your Inbox Venture capital (VC) funding increased by 11% in Q1 2024, driven by massive deals in generative artificial intelligence
In most of the business world — and the world in general — the default setting is caution, consensus, and, above all, a low tolerance for bad bets. Venture capitalists are not
Limited-scope advice is expected to largely be supplanted by gen AI-enabled tools Gen AI’s impact on financial advisers will likely reshape investment industry distribution strategies. The model used here predicts the percentage